Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "Sinclair Pharma" found in our extensive news archives from over 250 global news sources.
In addition to our news stories we have dozens of PubMed Articles about Sinclair Pharma for you to read. Along with our medical data and news we also list Sinclair Pharma Clinical Trials, which are updated daily. BioPortfolio also has a large database of Sinclair Pharma Companies for you to search.
Cited for his groundbreaking work on the underlying metabolic causes of aging MENLO PARK, Calif., Nov. 08, 2018 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics (MBTs) to treat age-related diseases, today announced that co-founder and scientific advisor Dr. David Sinclair is featured among TIME Magazine’s Heal...
NEW ORLEANS, Sept. 7, 2018 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until October 9, 2018 to file lead Read more...
NEW ORLEANS, Aug. 17, 2018 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., Read more...
LEO Pharma and MorphoSys have formed a strategic partnership to develop peptide-derived therapeutics. LEO Pharma will select lead molecules using...Read More... The post Deals and M&As this week: LEO Pharma, Valeo Pharma, Allergan appeared first on Pharmaceutical Technology.
Sun Pharma has signed a definitive agreement to acquire Pola Pharma for $1m. The acquisition is part of Sun Pharma’s...Read More... The post M&As this week: Sun Pharma, Genentech, CVS Health appeared first on Pharmaceutical Technology.
Karo Pharma develops and markets products for pharmacies and also directly to the healthcare sector. The specialty pharma company is said to have a strong presence in the The post EQT offers to buy Karo Pharma for $654m appeared first on Pharma Business review.
Following execution of MoUs with pharma companies─ Centaur, SG Pharma, Arco Lifesciences, BDH Pharma, Maharashtra Airport Development Company Ltd (MADC) has recently inked MoUs with pharma companies
Zealand Pharma has sold its future royalty streams and potential commercial milestones for Soliqua® 100/33/Suliqua® and Lyxumia®/Adlyxin® to Royalty Pharma...Read More... The post Deals this week: Zealand Pharma, Fulcrum Therapeutics, Forendo Pharma appeared first on Drug Development Technology.
China Resources Pharma will pay $667 million to acquire all the outstanding shares of Jiangzhong Pharma, a listed company. Three weeks ago, CR Pharma announced plans to acquire a stake in the parent company, Jiangzhong Group, for $613 million, which will, when added to its current holdings, give CR Pharma majority control of Jiangzhong Group. Jiangzhong Group, the parent, owns a 43% stake in Jiang...
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Accountant – Biotech / Pharma (Up to $70K) .MA-Boston, Publicly Traded Bio-Tech/Pharma Company is looking for a talented Staff Accountant to join their corporate headquarters located just west … Continue reading → Cet article #jobs #lifescience Accountant ...
NewsAlizé Pharma 3 is the third venture within the Alizé Pharma organization, whose first two companies were acquired by Jazz Pharmaceuticals in 2016 and Millendo Therapeutics in 2017.
Sun Pharma said it will acquire Japan-based Pola Pharma for around $1 million to strengthen its global dermatology presence.
In this interview, filmed at PharmaTelevision’s Oxford Studios, Dr Fintan Walton speaks with Stephen Parker, Partner at Celtic Pharma, a source of private equity and venture capital created in 2004. They discuss: • the drug assets acquired from companies including Xenova, IDEA and Inspire • Celtic Pharma’s Funds, their investors and their aims to raise US$750 M • attracting Big Pharma, ...
London, UK, 22nd November 2017 / Sciad Newswire / Further insights from the podium as the Pharma Integrates panellists tackle changing product and technological developments and a new patient-payer value chain, and ponder whether the future of pharma is in the hands of drug manufacturing companies
TORONTO, November 14, 2018 /PRNewswire/ -- FSD Pharma Inc. ("FSD Pharma" o la "Compañía") (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) han anunciado hoy el nombramiento Read more...
LONDON, July 24, 2018 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) ('Verona Pharma'), a clinical-stage biopharmaceutical company focused on developing and commercializing innovati...
FSD Pharma ist das Mutterunternehmen der FC Pharma Inc, welche ein lizensierter Marihuana Hersteller aus Kanada ist. Das Unternehmen aus Ontario hat sich die Zucht, Verarbeitung, Herstellung, Extra...
Results from our Smart Pharma survey, how pharma can implement digital tools at scale, how to boost cybersecurity and more.
Acquisition of Adapt Pharma underscores potential for companies in the opioid overdose market
The fact that thousands of stakeholders chose to follow pharma accounts on twitter deserves our attention. It says that there are people out there genuinely interested in what pharma has ...
WASHINGTON (dpa-AFX) - While reporting its second-quarter financial results today, ANI Pharmaceuticals Inc. (ANIP) said it has acquired WellSpring Pharma Services Inc. for $18 million in cash, to ...
November 13, 2018 (Investorideas.com Newswire) FSD Pharma Inc. ("FSD Pharma" or the "Company") (HUGE.CN) (FSDDF) (0K9.F) announced today that the license of its wholly-owned subsidiary, FV Pharma Inc. ("FV Pharma") under the Access to Cannabis for Medical Purposes Regulations ("ACMPR") has been migrated to the Cannabis Act and its regulations, effective November 8, 2018.
Sun Pharma has announced plans to acquire Pola Pharma for $1m, adding topical drug and injectables manufacturing capabilities to its network in Japan.
IRW-PRESS: FSD Pharma Inc.: FSD Pharma gibt Börsengang an der Börse Frankfurt bekannt FSD Pharma gibt Börsengang an der Börse Frankfurt bekannt TORONTO, 14. August 2018 / FSD Pharma Inc. (FSD Phar...
Chanelle Pharma has been named Ireland’s Pharma Industry Company of the Year 2018. The Pharma Industry Awards recognise and celebrate the most original and innovative individuals and companies that demonstrate excellence in the Irish Pharma sector... The post Chanelle named Ireland’s pharma industry company of the year 2018 appeared first on